Reuters logo
BRIEF-AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors
September 22, 2017 / 11:14 AM / in 3 months

BRIEF-AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors

Sept 22 (Reuters) - AbbVie Inc

* AbbVie and Bristol-Myers Squibb announce clinical research collaboration to evaluate a therapeutic regimen in advanced solid tumors

* Bristol-Myers Squibb Co - ‍specific terms of agreement were not disclosed.​

* Bristol-Myers Squibb Co - ‍AbbVie is sponsor conducting trial​

* Bristol-Myers Squibb Co - ‍study could expand into additional solid tumors in future​

* Bristol-Myers - collaboration to evaluate combination of abbVie’s ABBV-399 and co’s Opdivo in c-Met overexpressing non-small cell lung cancer​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below